ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Profit from core business operations before interest and taxes
3Y CAGR
+15.1%/yr
Annual compound
Percentile
P73
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $452.19M | -44.3% |
| 2025 | $811.13M | +4.4% |
| 2024 | $777.04M | +161.9% |
| 2023 | $296.69M | +187.5% |
| 2022 | $-338.90M | +32.9% |
| 2021 | $-504.94M | +28.0% |
| 2020 | $-701.04M | +4.8% |
| 2019 | $-736.56M | +17.7% |
| 2018 | $-895.05M | +18.1% |
| 2017 | $-1.09B | - |